eperisone has been researched along with Pain, Chronic in 3 studies
eperisone : A racemate that is an equimolar mixture of (R)- and (S)-eperisone. It is used (as the hydrochloride salt) as a muscle relaxant for the symptomatic treatment of muscle spasm and spasticity.
1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one : An aromatic ketone that is N-propylpiperidine in which a hydrogen at positon 2 of the propyl group is replaced by a p-ethylbenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether respectively radial extracoporeal shock wave therapy (rESWT) or a combination of rESWT, celecoxib and eperisone (rESWT + C + E) are superior in reducing pain in patients with chronic nonspecific low back pain (cnsLBP) compared to C + E alone (a standard treatment of this condition in China)." | 9.41 | Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial. ( Feng, Z; Guo, X; Li, L; Li, Y; Peng, Z; Schmitz, C; Yan, Z; Yang, Y; Zhang, Y, 2021) |
| "Eperisone, an analgesic and centrally acting muscle relaxant has been in use for the treatment of low back pain (LBP)." | 8.93 | Clinical efficacy and safety of eperisone for low back pain: A systematic literature review. ( Ali Kareem, S; Bavage, S; Dhadde, SB; Durg, S, 2016) |
| "To investigate whether respectively radial extracoporeal shock wave therapy (rESWT) or a combination of rESWT, celecoxib and eperisone (rESWT + C + E) are superior in reducing pain in patients with chronic nonspecific low back pain (cnsLBP) compared to C + E alone (a standard treatment of this condition in China)." | 5.41 | Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial. ( Feng, Z; Guo, X; Li, L; Li, Y; Peng, Z; Schmitz, C; Yan, Z; Yang, Y; Zhang, Y, 2021) |
| "Eperisone, an analgesic and centrally acting muscle relaxant has been in use for the treatment of low back pain (LBP)." | 4.93 | Clinical efficacy and safety of eperisone for low back pain: A systematic literature review. ( Ali Kareem, S; Bavage, S; Dhadde, SB; Durg, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X | 1 |
| Li, L | 1 |
| Yan, Z | 1 |
| Li, Y | 1 |
| Peng, Z | 1 |
| Yang, Y | 1 |
| Zhang, Y | 1 |
| Schmitz, C | 1 |
| Feng, Z | 1 |
| Bavage, S | 1 |
| Durg, S | 1 |
| Ali Kareem, S | 1 |
| Dhadde, SB | 1 |
| Rossi, M | 1 |
| Ianigro, G | 1 |
| Liberatoscioli, G | 1 |
| Di Castelnuovo, A | 1 |
| Grimani, V | 1 |
| Garofano, A | 1 |
| Camposarcone, N | 1 |
| Nardi, LF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Randomized, Controlled, Single Centre Trial to Assess the Efficacy and Safety of Radial Extracorporeal Shock Wave Therapy in Patients With Chronic Non-specific Low Back Pain[NCT03337607] | 150 participants (Anticipated) | Interventional | 2017-11-13 | Recruiting | |||
| Comparative Effects of Shockwave Therapy and Maitland's Lumbar Mobilization on Pain, Disability and Range of Motion in Patients With Mechanical Low Back Pain[NCT05404997] | 26 participants (Anticipated) | Interventional | 2022-03-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for eperisone and Pain, Chronic
| Article | Year |
|---|---|
Clinical efficacy and safety of eperisone for low back pain: A systematic literature review.
Topics: Chronic Pain; Clonidine; Humans; Low Back Pain; Pain Measurement; Propiophenones; Treatment Outcome | 2016 |
2 trials available for eperisone and Pain, Chronic